Things To Know Mounjaro uses dual hormone technology targeting GIP and GLP-1 receptors simultaneously Trulicity focuses solely on the GLP-1 pathway for blood sugar control Both medications require once-weekly injections administered subcutaneously Mounjaro typically produces greater A1C reductions averaging 2.0% to 2.3% Trulicity has a longer track record with over 10 years of real-world use Weight loss tends to be more significant with Mounjaro due to its dual action Side effects for both primarily involve gastrointestinal symptoms Mounjaro is available in higher maximum doses than Trulicity How Mounjaro and Trulicity Work Differently The fundamental difference in how these medications function explains much of their varying results

Current Evidence and Regulatory Status in the UK Potential Interactions and Combined Use Considerations Safety Risks and Side Effects to Be Aware Of MHRA Guidance on Unlicensed Peptides and Weight Loss Agents Speaking to a Healthcare Professional Before Use Scientific References Frequently Asked Questions What Are AOD 9604 and Retatrutide
Oral peptide formulations, even optimised ones, absorb only a fraction of the dose
Carey KA, Kensler TW, Fishbein JC (2001) Kinetic constraints for the thiolysis of 4-methyl-5-(pyrazin-2-yl)-1,2-dithiole-3-thione (oltipraz) and related dithiole-3-thiones in aqueous solution
The prices will take effect in mid-2026
This peptide stimulates GH by triggering the somatotropic cells in the pituitary gland